UnfairGaps
🇮🇳India

GMP अनुपालन विफलता पर लाइसेंस निलंबन

3 verified sources

Definition

Failure to comply with GMP batch record requirements under revised Schedule M results in license suspension, affecting over 60% of SMEs and threatening operations for 8,500+ units.

Key Findings

  • Financial Impact: ₹2.5 billion turnover threshold for compliance categorization; license suspension halts all revenue; 60%+ SMEs at shutdown risk by Dec 2025.
  • Frequency: Ongoing until Dec 31, 2025 deadline for MSMEs.
  • Root Cause: Manual batch record execution lacks validation, documentation integrity, and timely review leading to non-compliance.

Why This Matters

This pain point represents a significant opportunity for B2B solutions targeting Pharmaceutical Manufacturing.

Affected Stakeholders

Plant Manager, Quality Head, Compliance Officer

Action Plan

Run AI-powered research on this problem. Each action generates a detailed report with sources.

Methodology & Sources

Data collected via OSINT from regulatory filings, industry audits, and verified case studies.

Related Business Risks